Skip to main content

Incannex welcomes world-leading psychedelics experts to advisory board

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Incannex Healthcare Ltd (ASX:IHL, NASDAQ: IXHL) director Peter Widdows tells Proactive the company has appointed three world-renowned psychedelic therapy and science experts to its Clarion Clinics Group Advisory Board. The Clarion Clinics Groups Pty Ltd is a collaborative venture between Incannex and three leading Australian psychedelics experts - Dr Paul Liknaitzky, Professor Suresh Sundram and Sean O’Carroll.

Contact Details

Proactive Investors

Jonathan Jackson

+61 413 713 744

Jonathan@proactiveinvestors.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  268.46
+3.45 (1.30%)
AAPL  304.99
+2.74 (0.91%)
AMD  449.59
+2.01 (0.45%)
BAC  51.49
+0.26 (0.51%)
GOOG  383.47
-1.43 (-0.37%)
META  607.38
+2.32 (0.38%)
MSFT  419.09
-1.97 (-0.47%)
NVDA  219.51
-3.96 (-1.77%)
ORCL  189.77
+1.61 (0.86%)
TSLA  417.85
+0.59 (0.14%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.